Prepared by:
ECRI, Plymouth Meeting, PA
Health Technology Assessment Group
File Name Description Software Version File Size _________________________________________________________________________________________________ 01front.doc Microsoft Word® Document MS Word® 97 SR-1 26KB 3 pages Contents: Title Page, Preface _________________________________________________________________________________________________ 02cont.doc Microsoft Word® Document MS Word® 97 SR-1 31KB 4 pages Contents: Table of Contents _________________________________________________________________________________________________ 03abstr.doc Microsoft Word® Document MS Word® 97 SR-1 24KB 3 pages Contents: Structured Abstract _________________________________________________________________________________________________ 04summ.doc Microsoft Word® Document MS Word® 97 SR-1 52KB 8 pages Contents: Summary _________________________________________________________________________________________________ 05body.doc Microsoft Word® Document MS Word® 97 SR-1 350KB 60 pages Contents: Evidence Report, Chapters 1, 2, and 3 Chapter 1. Introduction Chronic Renal Failure, Social Security Insurance, Purpose and Scope of This Evidence Report Chapter 2. Phase 1: Review of the Available Evidence in the Published Literature Methodology, Focus and Refinement of Topic, Measuring Inability To Work, Table 1. Impairment and disability terminology, Evidence Model, Figure 1. Adult renal failure evidence model, Literature Searches: Summary, Literature Searches: Final Summary of Relevant Literature, Results Chapter 3. Phase 2: Analysis of USRDS Data Description of USRDS Data, Methodology, Results, Table 2. Comparison of DMMS Wave 2 patients to all patients in the USRDS database, Table 3. Final subgroup of patients for proposed analysis, Table 4. Statistically significant differences between patients in the final data set and those excluded from this data set, Table 5. Correlations between measures of employment and ability to work, Table 6. Correlations between employment measures and functional status measures, Table 7. Correlations between clinical and laboratory measurements and measures of employment and self-reported ability to work, Figure 2. Hematocrit values (percent) versus hemoglobin values (g/dL), Table 8. Results of logistic regression on each DMMS Wave 2 medical questionnaire subsection, Table 9. Employment status of patients in DMMS Wave 2, under age 65, Table 10. Statistics about patients who continue working, Table 11. Working status by sex, Table 12. Occupation type of individuals continuing to work full time throughout study, Table 13. Comparison of education level of patients who worked throughout the duration of DMMS Wave 2 study versus those who did not, Table 14. Self-reported ability to work full time at start of study versus employment status, Table 15. Employment status versus self-reported ability to work at followup, Table 16. Employment status at time of patient interview about 1 monthafter study start date (according to medical records) _________________________________________________________________________________________________ 06concl.doc Microsoft Word® Document MS Word® 97 SR-1 24KB 2 pages Contents: Chapter 4. Conclusions _________________________________________________________________________________________________ 07futur.doc Microsoft Word® Document MS Word® 97 SR-1 56KB 3 pages Contents: Chapter 5. Future Research _________________________________________________________________________________________________ 08refs.doc Microsoft Word® Document MS Word® 97 SR-1 32KB 5 pages Contents: References _________________________________________________________________________________________________ 09etab1.doc Microsoft Word® Document MS Word® 97 SR-1 69KB 7 pages Contents: Evidence Table 1. Evidence regarding predictors of disability of ESRD patients as defined by employment _________________________________________________________________________________________________ 10etab2.doc Microsoft Word® Document MS Word® 97 SR-1 57KB 2 pages Contents: Evidence Table 2. Rejected studies with some relevant data _________________________________________________________________________________________________ 11biblio.doc Microsoft Word® Document MS Word® 97 SR-1 66KB 7 pages Contents: Bibliography _________________________________________________________________________________________________ 12appa.doc Microsoft Word® Document MS Word® 97 SR-1 209KB 44 pages Contents: Appendix A: Questionnaires Included in the DMMS Wave 2 Study _________________________________________________________________________________________________ 13appb.doc Microsoft Word® Document MS Word® 97 SR-1 28KB 3 pages Contents: Appendix B: Summary of Significant Correlations for Validity Analyses _________________________________________________________________________________________________ 14appc.doc Microsoft Word® Document MS Word® 97 SR-1 59KB 4 pages Contents: Appendix C: Table C-1. Scoring of Kidney Disease Quality-of-Life Questionnaire _________________________________________________________________________________________________ 15appd.doc Microsoft Word® Document MS Word® 97 SR-1 282KB 30 pages Contents: Appendix D: Descriptive Statistics Table D-1. Categorical disease states by work status, Table D-2. Categorical disease states by employment status, Table D-3. Work status: descriptive statistics of symptoms and laboratory values, Table D-4. Comparison of KDQOL(TM) subscales based on employment status Table D-5. Employment status at study start date by laboratory variables, Table D-6. Demographic and employment categorical variables _________________________________________________________________________________________________ 16appe.doc Microsoft Word® Document MS Word® 97 SR-1 123KB 16 pages Contents: Appendix E: Sample Analysis of DMMS Wave 2 Data Table E-1. Variables for which data were imputed, Figure E-1. ROC curve of physiologic variables for prediction of working status at 9- to 12-month followup, Figure E-2. ROC curve of demographic and physiologic variables for prediction of working status at 9- to 12-month followup _________________________________________________________________________________________________ 17acro.doc Microsoft Word® Document MS Word® 97 SR-1 22KB 2 pages Contents: List of Acronyms and Abbreviations _________________________________________________________________________________________________
AHRQ Publication No. 00-E013
Current as of May 2000
Internet Citation:
Determinants of Disability in Patients With Chronic Renal Failure. File Inventory, Evidence Report/Technology Assessment Number 13. AHRQ Publication No. 00-E013, May 2000. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/renalinv.htm
Return to Evidence-based Practice
Clinical Information
AHRQ Home Page
Department of Health and Human Services